Steroid-Induced Metabolic Dysfunction After Kidney Transplantation: Mechanisms, Risk Factors, and Preventive Strategies
Keywords:
Steroid-Induced Metabolic Dysfunction, Kidney TransplantationAbstract
Background: Steroids remain essential components of immunosuppressive therapy in kidney transplantation, yet theirmetabolic adverse effects continue to challenge long-term graft and patient outcomes. Steroid-induced metabolicdysfunction encompasses a spectrum of disturbances, including impaired glucose tolerance, new-onset diabetes after transplantation (NODAT), dyslipidemia, central adiposity
Downloads
References
Kasiske BL, Zeier MG, Chapman JR, et al. KDIGO clinical practice guideline for the care of kidney transplant recipients. Am J Transplant. 2009;9(suppl 3):S1-S155.
Downloads
Published
How to Cite
Issue
Section
License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
NonCommercial — You may not use the material for commercial purposes.
No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.


